NL-OMON34339招募中不适用
the pharmaprofile; towards tailor-made pharmacotherapy for the terminally ill adult patient. - Pharmaprofile terminally ill adult
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-Terminal illness
- •-Prognosis survival more than 2 days and less than 3 months
- •-Administration of morphine, haloperidol and/or midazolam
- •-Informed consent
排除标准
- •-Withdrawal of informed consent
- •-No blood sample obtained
研究者
相似试验
尚未招募
2 期
Clinical Efiicacy of Marichyadi Lepa and Abhayarishta on Shvitra (Vitiligo)CTRI/2017/02/007929IPGT and RA60
已完成
不适用
Development of patient individualization medication method of ampicillin/sulbactam and vancomycin when cardiovascular surgerycardiovascular surgery conditionJPRN-UMIN000007356Kagoshima University hospital50
进行中（未招募）
不适用
Individualised drug therapy based on pharmacogenomics: focus on carboxylesterase 1 (CES1) - INDICES/WP2Healthy volunteers with special genotypesMedDRA version: 16.0Level: LLTClassification code 10053349Term: Pharmacokinetic studySystem Organ Class: 100000004848EUCTR2011-004815-22-DKResearch Institute of Biological Psychiatry Sct. Hans
已完成
不适用
therapeutic drug monitoring: towards tailored dosing of adalimumab in rheumatoid arthritisrheumatoide arthritis10003816NL-OMON41716Reade, centrum voor Revalidatie en Reumatologie55
已完成
不适用
Study for personalized medicine based on pharmacokinetics and pharmacodynamics concerned with therapeutic drug of nontuberculous mycobacterium.JPRN-UMIN000020406Center for Infectious Disease and Infection Control10